116 related articles for article (PubMed ID: 1723035)
1. CD5-T lymphocytes in renal transplant recipients.
McKay PJ; Kyle B; McLaren A; McMillan MA; Lucie NP
Clin Lab Haematol; 1991; 13(4):335-40. PubMed ID: 1723035
[TBL] [Abstract][Full Text] [Related]
2. Recovery of CD3+ and CD5- lymphocyte subpopulation after autologous bone marrow transplantation and chemotherapy.
McKay PJ; McLaren A; Andrews LM; Lucie NP
J Clin Pathol; 1991 Mar; 44(3):259-61. PubMed ID: 1707418
[TBL] [Abstract][Full Text] [Related]
3. Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection.
Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
Transplant Proc; 1992 Feb; 24(1):315. PubMed ID: 1531714
[No Abstract] [Full Text] [Related]
4. In vivo modulation of the distribution of thymocyte subsets: effects of estrogen on the expression of different T cell receptor V beta gene families in CD4-, CD8- thymocytes.
Screpanti I; Meco D; Morrone S; Gulino A; Mathieson BJ; Frati L
Cell Immunol; 1991 May; 134(2):414-26. PubMed ID: 1708703
[TBL] [Abstract][Full Text] [Related]
5. Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.
Spour EF; Leemhuis T; Jenski L; Redmond R; Fillak D; Jansen J
Clin Exp Immunol; 1990 Apr; 80(1):114-21. PubMed ID: 1691061
[TBL] [Abstract][Full Text] [Related]
6. Rejection prophylaxis with sequential OKT3 and CSA after kidney transplantation.
Weimar W; Hesse CJ; Vaessen LM; Hendriks GF; Jutte NH; Jeekel J
Biotherapy; 1990; 2(3):267-70. PubMed ID: 1698424
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT
Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863
[No Abstract] [Full Text] [Related]
8. T gamma/delta lymphocytes in renal transplant recipients.
Raasveld MH; Bloemena E; Surachno S; ten Berge RJ
Nephrol Dial Transplant; 1992; 7(6):530-3. PubMed ID: 1377808
[TBL] [Abstract][Full Text] [Related]
9. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.
Drobyski WR; Piaskowski V; Ash RC; Casper JT; Truitt RL
Transplantation; 1990 Oct; 50(4):625-32. PubMed ID: 1699309
[TBL] [Abstract][Full Text] [Related]
10. Immune monitoring after renal transplantation. II. Post-transplant disturbances in the CD3 complex expression may be caused by immunosuppression.
Nowaczyk M; Górski A; Małdyk M; Juskowa J; Wyzgal J; Modlińska M; Bukowska J; Morzycka-Michalik M
Arch Immunol Ther Exp (Warsz); 1991; 39(3):297-9. PubMed ID: 1839763
[TBL] [Abstract][Full Text] [Related]
11. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels.
Di Paolo S; Schena A; Morrone LF; Manfredi G; Stallone G; Derosa C; Procino A; Schena FP
Transplantation; 2000 May; 69(10):2049-54. PubMed ID: 10852595
[TBL] [Abstract][Full Text] [Related]
12. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
Dauphinée MJ; Tovar Z; Ballester A; Talal N
Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological analysis of T lymphocyte subpopulations in needle core biopsies from OKT3-treated renal allograft recipients.
Chauhan B; Mohanakumar T; Flye MW
Transplantation; 1990 Dec; 50(6):1058-60. PubMed ID: 2147792
[No Abstract] [Full Text] [Related]
14. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
[TBL] [Abstract][Full Text] [Related]
16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
17. Decreased lymphokine-activated killer cells in kidney transplant recipients. Correlation with a diminished number of CD3-/NKH1+ cells.
Alard P; Lantz O; Ramirez A; Perrot JY; Chavanel G; Fries D; Charpentier B; Senik A
Transplantation; 1990 Aug; 50(2):250-7. PubMed ID: 1696407
[TBL] [Abstract][Full Text] [Related]
18. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
[TBL] [Abstract][Full Text] [Related]
19. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation.
Bierer BE; Burakoff SJ; Smith BR
Blood; 1989 Apr; 73(5):1359-66. PubMed ID: 2467708
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
Okunewick JP; Kociban DL; Machen LL; Buffo MJ
Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
